Literature DB >> 33160003

Circular RNA TGFBR2 acts as a ceRNA to suppress nasopharyngeal carcinoma progression by sponging miR-107.

Wanpeng Li1, Hanyu Lu1, Huan Wang1, Xianhui Ning2, Quan Liu1, Huankang Zhang1, Zhuofu Liu1, Jingjing Wang1, Weidong Zhao1, Yurong Gu1, Houyong Li1, Xicai Sun1, Li Hu1, Dehui Wang3.   

Abstract

Circular RNAs (circRNAs) act as competing endogenous RNAs, which are involved in the regulation of many types of cancers. They primarily function by sponging microRNAs (miRNAs) and influencing the expression of miRNA by target messenger RNA. However, the role of circRNAs in the progression of nasopharyngeal carcinoma (NPC) remains largely unclear. In this study, differentially expressed miRNAs associated with NPC were screened using microarray analyses, from which miR-107 was identified. Increased miR-107 expression was associated with poor prognosis in NPC, and miR-107 promoted the proliferation and migration of NPC cells. TGFBR2 was identified as the direct target of miR-107, which could reverse its effect on NPC cells. Furthermore, the expression of circTGFBR2 was downregulated in NPC tissue samples, while circTGFBR2 overexpression correlated with favorable prognosis in NPC. Functionally, circTGFBR2 overexpression inhibited the proliferation and migration of NPC cells both in vitro and in vivo. Further analysis showed that circTGFBR2 sponged miR-107, leading to the upregulation of TGFBR2 expression and suppression of NPC progression. Therefore, circTGFBR2 may serve as a novel tumor suppressive factor and potential target for new therapies in NPC patients.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Circular RNA; Nasopharyngeal carcinoma; TGFBR2; circTGFBR2; miR-107

Mesh:

Substances:

Year:  2020        PMID: 33160003     DOI: 10.1016/j.canlet.2020.11.001

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  15 in total

1.  Diagnostic and prognostic value of circRNAs expression in head and neck squamous cell carcinoma: A meta-analysis.

Authors:  Huajun Feng; Dingting Wang; Jinping Liu; Longfei Zou; Shengen Xu; Zhuoping Liang; Gang Qin
Journal:  J Clin Lab Anal       Date:  2022-05-20       Impact factor: 3.124

Review 2.  CircRNAs and their regulatory roles in cancers.

Authors:  Mei Tao; Ming Zheng; Yanhua Xu; Shuo Ma; Weiwei Zhang; Shaoqing Ju
Journal:  Mol Med       Date:  2021-08-26       Impact factor: 6.354

3.  Circ_0078607 inhibits the progression of ovarian cancer via regulating the miR-32-5p/SIK1 network.

Authors:  Yangqiu Jin; Hui Wang
Journal:  J Ovarian Res       Date:  2022-01-04       Impact factor: 4.234

4.  Hsa_circ_0007637 Facilitates Nasopharyngeal Carcinoma Progression by Sponging miR-636/TPD52 Axis.

Authors:  Yihong Wang; Manyi Li; Chen Pan; Haiping Huang; Xiaoqing Hu; Jisheng Liu
Journal:  Cancer Manag Res       Date:  2021-12-30       Impact factor: 3.989

5.  Circular RNA circRNF13 inhibits proliferation and metastasis of nasopharyngeal carcinoma via SUMO2.

Authors:  Yongzhen Mo; Yumin Wang; Shuai Zhang; Fang Xiong; Qijia Yan; Xianjie Jiang; Xiangying Deng; Yian Wang; Chunmei Fan; Le Tang; Shanshan Zhang; Zhaojian Gong; Fuyan Wang; Qianjin Liao; Can Guo; Yong Li; Xiaoling Li; Guiyuan Li; Zhaoyang Zeng; Wei Xiong
Journal:  Mol Cancer       Date:  2021-08-31       Impact factor: 27.401

6.  CircTMTC1 contributes to nasopharyngeal carcinoma progression through targeting miR-495-MET-eIF4G1 translational regulation axis.

Authors:  Yajie Zhao; Chao Li; Yan Zhang; Zhanzhan Li
Journal:  Cell Death Dis       Date:  2022-03-18       Impact factor: 9.685

7.  Circular RNA SET domain protein 3 promotes nasopharyngeal carcinoma proliferation, cisplatin resistance, and protein kinase B / mammalian target of rapamycin pathway activation by modulating microRNA-147a expression.

Authors:  Gang Deng; Fei Wang; YiSa Song
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

8.  ceRNA network development and tumor-infiltrating immune cell analysis in hepatocellular carcinoma.

Authors:  Li Chen; Weijie Zou; Lei Zhang; Huijuan Shi; Zhi Li; Caifang Ni
Journal:  Med Oncol       Date:  2021-06-19       Impact factor: 3.064

9.  Circular RNA: A novel type of biomarker for glioma (Review).

Authors:  Wei Sun; Huandi Zhou; Xuetao Han; Liubing Hou; Xiaoying Xue
Journal:  Mol Med Rep       Date:  2021-06-24       Impact factor: 2.952

Review 10.  Regulation of Ferroptosis by Non-Coding RNAs in Head and Neck Cancers.

Authors:  Pei-Ling Hsieh; Shih-Chi Chao; Pei-Ming Chu; Cheng-Chia Yu
Journal:  Int J Mol Sci       Date:  2022-03-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.